Turnover
≈ €190,000 estimated
The micro format states no turnover.
EKLOSIUM
Lifetime
1 annual account with figurespeak €17,840 (2025)
€17,840
peak €6,365 (2025)
€6,365
peak €8,865 (2025)
€8,865
€12,567
Board1 name since 2024
1 director
Documentsfilings and deeds
26-05-202626 days late
2025micro format
First year with figures
Key points
from the 2025 annual accountsStarting capital
€2,500 100 shares
2025 accounts filed 26 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 11,278 companies had the same profile as EKLOSIUM has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,278 companies, not a prediction for EKLOSIUM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Daily manager
- 99 sharesdeed of 28-11-2024
- 1 sharedeed of 28-11-2024
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1016650070
Incorporation
Founding capital of €2,500, 100 shares · Founders: and · Appointment: (director and day-to-day manager) · published on 28-11-2024 · Gazette deed
First establishment
Groenstraat 217, Schaerbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| EKLOSIUM Schaerbeek | €21,432 | €17,840 | 41.4% | - |
| HERBORISTERIE KUSA Schaerbeek | €22,675 | €19,822 | -33.3% | - |
| GRACE PARTNER Quaregnon | €19,066 | €17,089 | 38.6% | - |
| FORMAPHARMA Andenne | €17,739 | €16,079 | 81.5% | - |
| DEROPHARMA Waterloo | €29,143 | €18,590 | 62.7% | - |
| BLAIRVACQ Jean François Waremme | €29,415 | €18,240 | 43.8% | - |
| InEssence Studio Auderghem | €29,309 | €21,046 | 60.8% | - |
These companies have the same main activity as EKLOSIUM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €17,700 and €29,400, founded between 2023 and 2025.
Official details
Source: KBO- Status
- Active since 26-11-2024Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.366.843.9461030 Schaerbeek, since 26-11-2024
- Financial year end
- 30 September
- Peppol
- Reachable since 24-12-2025
Insights on EKLOSIUM
EKLOSIUM has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8,865 and a net result of €6,365.
Its solvency ranks better than 57% of 25,281 sector peers (NACE 47, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about EKLOSIUM
- What is the company number of EKLOSIUM?
- The company number of EKLOSIUM is 1016.650.070. The VAT number is the same number with BE in front: BE 1016.650.070.
- Where is EKLOSIUM based?
- The registered office is at Groenstraat 217, 1030 Schaerbeek.Company details
- What does EKLOSIUM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of EKLOSIUM?
- EKLOSIUM is a private limited company (BV).
- When was EKLOSIUM founded?
- EKLOSIUM was founded on 26-11-2024.
- Is EKLOSIUM still active?
- Yes, EKLOSIUM is an active enterprise in the KBO register.
- What is the turnover of EKLOSIUM?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €17,840 and 138 comparable companies (NACE 477). It probably lies between €70,000 and €400,000. It is a rough estimate.Financials
- Is EKLOSIUM profitable?
- In financial year 2025, EKLOSIUM made a profit of €6,365.
- Where can I find the annual accounts of EKLOSIUM?
- EKLOSIUM filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.